8-K/A XBRL

FORM 8-K/A

Company: Moleculin Biotech, Inc.
Filed: May 13, 2024
Period of Report: May 13, 2024
Accession Number: 0001437749-24-016162

View Document ↗ View on SEC.gov ↗